MyChesCo on MSN4h
FDA Grants Fast Track Designation to PleoPharma’s PP-01 for Cannabis Withdrawal SyndromePleoPharma, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback